Medical Condition News

RSS

Gradual reduction in smoking as successful as abrupt quitting

Although many smokers try to quit by selecting a "quit day" and going cold turkey, a new Cochrane review finds that quitting gradually might work just as well.

20 Mar 2010

HHS awards more than $372M to 44 communities to support public health efforts

The U.S. Department of Health and Human Services today announced awards of more than $372 million to 44 communities, to support public health efforts to reduce obesity and smoking, increase physical activity and improve nutrition.

20 Mar 2010

Portable ultrasound device to treat chronic joint pain from arthritis

In recent years, doctors have used ultrasound to effective treat joint pain from arthritis and other ailments without the use of drugs. The drawback to these treatments, however, is that they can only be administered in a doctor's office or clinic, since the ultrasound devices currently used are bulky and expensive.

20 Mar 2010

Inexpensive lab tests can help protect people from chronic kidney disease

No matter what Washington does on health reform, there's a lot you can do to reform your own health -- and two of the best places to start are your kidneys.

20 Mar 2010

Unrealized educational expectations do not always lead to frustration and anxiety

"Is There a Downside to Shooting for the Stars? Unrealized Educational Expectations and Symptoms of Depression," which was published in the American Sociological Review (http://asr.sagepub.com/cgi/content/full/75/1/151), is the first large, national study to look at the mental health consequences of failing to meet educational expectations.

20 Mar 2010

Genetic study may help develop potential treatment strategies for stiff skin syndrome

By studying the genetics of a rare inherited disorder called stiff skin syndrome, researchers at the Johns Hopkins University School of Medicine have learned more about scleroderma, a condition affecting about one in 5,000 people that leads to hardening of the skin as well as other debilitating and often life-threatening problems.

20 Mar 2010

Investigation on spread of illegal drug use in social networks

Recent studies have shown that behaviors such as happiness, obesity, smoking and altruism are "contagious" within adult social networks. In other words, your behavior not only influences your friends, but also their friends and so on.

20 Mar 2010

Hospital costs for treating septicemia increased from $4.1 billion in 1997 to $12.3 billion in 2007

The hospital costs for treating septicemia increased by an average of nearly 12 percent each year from 1997 to 2007, according to the latest News and Numbers from the Agency for Healthcare Research and Quality. Treating this potentially deadly blood infection increased from $4.1 billion in 1997 to $12.3 billion in 2007.

20 Mar 2010

$Stress fracture: Causes and treatment strategies$

Stress fracture: Causes and treatment strategies

When pain from increased physical activity doesn’t go away in a couple of days, the cause could be a stress fracture. The March issue of Mayo Clinic Health Letter covers these tiny, partial bone fractures, why they occur and how they are treated.

20 Mar 2010

Turning microRNAs into novel drugs

Researchers around the globe are working on turning microRNAs, over 5,000 of which already have been identified, into novel drugs for a wide range of applications, reports Genetic Engineering & Biotechnology News (GEN). These noncoding single-stranded RNAs act through binding to complementary mRNA sequences, thus preventing their translation into protein or accelerating mRNA breakdown, according to the March 15 issue of GEN.

20 Mar 2010

Winner of 2010 European Magnetic Resonance Award

Dr John Griffiths, a Cancer Research UK-funded scientist, has received the 2010 European Magnetic Resonance Award for Basic Sciences.

20 Mar 2010

High dose of Zocor could lead to muscle injury, warns FDA

The U.S. Food and Drug Administration today warned patients and healthcare providers about the potential for increased risk of muscle injury from the cholesterol-lowering medication Zocor (simvastatin) 80 mg.

20 Mar 2010

China Sky One Medical's Myocardial Infarction and Urine Microalbumin Diagnostic Kits receive CE certification

China Sky One Medical, Inc., a leading fully integrated pharmaceutical company producing over-the-counter drugs in the People's Republic of China, today announced the receipt of Conformite Europeenne (CE) certification for its Myocardial Infarction and Urine Microalbumin Diagnostic Kits. The CE marking certifies that the two products have met the European Union health and safety standards and are approved for sale in the 27 EU countries and four members of the European Free Trade Association.

20 Mar 2010

Innovative tissue damage preventing cardiac scaffold awarded Rappaport Prize for biomedical research

Prof. Smadar Cohen, head of the University's Avram and Stella Goldstein-Goren Department of Biotechnology Engineering, has been awarded the prestigious Rappaport Prize for Excellence in Biomedical Research, an award totaling $100,000. The prize, given by Israel's Rappaport Foundation, is presented annually to a researcher whose research has either significantly advanced or has the potential to significantly advance any medical or biomedical field.

20 Mar 2010

SoCalBio to host forum on latest medical devices for treating obesity

The Southern California Biomedical Council will host a discussion on the latest medical devices for treating obesity during its networking forum on Thursday, March 25th (7:00 - 9:30 am) at the UC Irvine University Club.

20 Mar 2010

Melancholy - not just a ‘state of mind’ but maybe a mental illness

Melancholia was first identified by the Greek physician Hippocrates, who described sufferers as being plagued with ''fears and despondencies''. But due to lack of exact biochemical and clinical features this condition has been struck off the Diagnostic and Statistical Manual of Mental Disorders used worldwide to diagnose mental illnesses.

19 Mar 2010

Cedars-Sinai Neurovascular Center's clinical trial of minimally invasive stenting procedure for TIA

Individuals between 30 and 80 years of age, who have had a transient ischemic attack (TIA) or non-severe stroke within the past 30 days, and who cannot be treated surgically, may be eligible to participate in a Phase III clinical trial of a minimally invasive stenting procedure at the Cedars-Sinai Neurovascular Center. The study will focus specifically on patients who have had an intracranial artery narrowed by at least 70 percent and who are experiencing recurrent strokes or TIAs despite being on anti-clotting medication.

19 Mar 2010

ViroPharma to present Cinryze data at Southern European Allergy Society congress

ViroPharma Incorporated today announced the presentation of two abstracts relating to Cinryze™ (C1 esterase inhibitor [human]) therapy at the First International Congress of the Southern European Allergy Society in Florence, Italy.

19 Mar 2010

ViroPharma launches 'Ryze Above' for patients with HAE enrolled in CINRYZESolutions support program

ViroPharma Incorporated today announced the launch of 'Ryze Above' (www.ryzeabove.com), an exclusive patient resources program within the company's patient support program, CINRYZESolutions®. The Ryze Above program was created for HAE patients prescribed Cinryze, the first and only drug specifically approved to help prevent swelling and/or painful attacks in teenagers and adults with HAE.

19 Mar 2010

Synergy Pharmaceuticals commences dosing in Phase IIa clinical trial of SP-304 in CC patients

Synergy Pharmaceuticals, Inc., a developer of new drugs to treat gastrointestinal disorders and diseases, announced today the initiation of dosing in a Phase IIa clinical trial of SP-304 in patients with chronic constipation (CC). This is a Phase IIa, randomized, double-blind, placebo-controlled, 14-day repeat, oral, dose-escalation study in patients with chronic constipation.

19 Mar 2010

Medical Condition News

Gradual reduction in smoking as successful as abrupt quitting

HHS awards more than $372M to 44 communities to support public health efforts

Portable ultrasound device to treat chronic joint pain from arthritis

Inexpensive lab tests can help protect people from chronic kidney disease

Unrealized educational expectations do not always lead to frustration and anxiety

Genetic study may help develop potential treatment strategies for stiff skin syndrome

Investigation on spread of illegal drug use in social networks

Hospital costs for treating septicemia increased from $4.1 billion in 1997 to $12.3 billion in 2007

Stress fracture: Causes and treatment strategies

Turning microRNAs into novel drugs

Winner of 2010 European Magnetic Resonance Award

High dose of Zocor could lead to muscle injury, warns FDA

China Sky One Medical's Myocardial Infarction and Urine Microalbumin Diagnostic Kits receive CE certification

Innovative tissue damage preventing cardiac scaffold awarded Rappaport Prize for biomedical research

SoCalBio to host forum on latest medical devices for treating obesity

Melancholy - not just a ‘state of mind’ but maybe a mental illness

Cedars-Sinai Neurovascular Center's clinical trial of minimally invasive stenting procedure for TIA

ViroPharma to present Cinryze data at Southern European Allergy Society congress

ViroPharma launches 'Ryze Above' for patients with HAE enrolled in CINRYZESolutions support program

Synergy Pharmaceuticals commences dosing in Phase IIa clinical trial of SP-304 in CC patients

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Latest News